TAM PAP HPV TEST

The Tam-Pap test process is unlike any other HPV test currently available in so far as it:
• Allows a women to self sample within the amenity and security of her own home;
• The process in “non-invasive” in comparison to other detection tests for HPV and does not require the initial intervention of a medical practitioner;
• The test analysis utilises a standard laboratory process with routine laboratory equipment and can be replicated in other localities;
• The turnaround time for analysis and interpretation of results is rapid and will be easily facilitated through the Company’s proprietary software platform;

The Tam Pap test has been approved by the TGA and lodgement for FDA approval for the sale and distribution of the product in the United States has already been made. The key target markets for the Tam Pap test include the United States, the United Kingdom, Central Europe, China, India and New Zealand.